Organization: Health Canada
Year: 2024
Month: July
Request Number: A-2023-001625
Request Summary: Adverse Drug Reactions (ADRs) for Mesalazine. Report numbers: E2B_06860106, E2B_06879090, E2B_06897644. ADRs for Immunoglobulin (human). Report numbers: E2B_06848171, 001069979, 001069986, E2B_06894900, E2B_06839700, E2B_06886486, 001069997.
Disposition: Disclosed in part
Number of pages: 129